A fixed-dose combination tablet offers the advantages of patient compliance and convenience, although it potentially limits the scope for dosage adjustment. A small study on the pharmacokinetic ...

Pfizer and Myovant have begun a late-stage trial of their potential uterine fibroid drug relugolix, as part of a contraceptive combination tablet. The FDA is already reviewing data from two ...

Johnson & Johnson has been given FDA approval for Akeega, a combination tablet for first-line treatment of adults with BRCA-positive metastatic castration-resistant prostate cancer (mCRPC).

The all in one modular PC, laptop, tablet and desktop combo from Compal recently won an iF Design Award and we analyze it ...